Skip to main content
SpringerLink
Log in

Prostate cancer

Saturation biopsy does not accurately localize tumors

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Precise localization of prostate cancer is essential for the success of focal therapies. Despite suggestions that saturation biopsy might be useful in this regard, a new study implies it cannot accurately pinpoint prostate tumors. Research efforts would perhaps be better focused on identifying which patients require treatment for clinically localized prostate cancer in the first place.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250–1261 (2008).

    Article  CAS  Google Scholar 

  2. Bianco, F. J. Jr, Scardino, P. T. & Eastham, J. A. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66 (Suppl. 5), 83–94 (2005).

    Article  Google Scholar 

  3. Sartor, A. O. et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology 72 (Suppl. 6), S12–S24 (2008).

    Article  Google Scholar 

  4. Shukla-Dave, A. et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int. 99, 786–793 (2007).

    Article  CAS  Google Scholar 

  5. Taneja, S. S. & Mason, M. Candidate selection for prostate cancer focal therapy. J. Endourol. 24, 835–841 (2010).

    Article  Google Scholar 

  6. Falzarano, S. M. et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology doi:10.1016/j.urology.2009.11.067.

  7. Parker, C., Muston, D., Melia, J. & Dearnaley, D. A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br. J. Cancer 94, 1361–1368 (2006).

    Article  CAS  Google Scholar 

  8. Welch, H. G. & Black, W. C. Overdiagnosis in cancer. J. Natl Cancer Inst. 102, 605–613 (2010).

    Article  Google Scholar 

  9. Andriole, G. L. et al. Mortality results from a randomized prostate-cancer screening trial. N. Engl J. Med. 360, 1310–1319 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Urology and Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-42 New Orleans, 70112, LA, USA

    Oliver Sartor

Authors
  1. Oliver Sartor
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sartor, O. Saturation biopsy does not accurately localize tumors. Nat Rev Urol 7, 479–480 (2010). https://doi.org/10.1038/nrurol.2010.139

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2010.139

  • Springer Nature Limited

This article is cited by

Search

Navigation